HTR2B and congenital bilateral aplasia of vas deferens from CFTR mutation: The aim of this study was to assess the possibility of slowing or treating CAVD by genetically deleting or pharmacologically inhibiting 5-HT2B in a high-cholesterol diet Notch1+/- mouse model.